论文信息 - A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial - 字舞流文

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

R. Huddart | G. Rustin | G. Mead | M. Cullen | P. Cook | S. Stenning | P. Harper | M. Mason | on behalf of the Medical Research Council Lung Cancer Party